Schizophrenia: Treatment Targets Beyond Monoamine Systems
- 10 February 2011
- journal article
- review article
- Published by Annual Reviews in Annual Review of Pharmacology and Toxicology
- Vol. 51 (1) , 189-209
Abstract
We develop the proposal in this review that schizophrenia is a syndrome made up of component symptom complexes, each with distinctive clinical correlates, pathophysiology, and selective treatments. Psychosis is the necessary component of the syndrome; it has a young-adult onset and is sensitive to current antipsychotic drugs. Cognitive dysfunction often precedes psychosis onset, does not present an episodic course, and is poorly responsive to antipsychotic drugs. Treatments for cognition are being developed largely on the basis of animal pharmacology. Drugs for component symptom complexes will theoretically be coadministered to independent symptomatic end points. Animal models, some with genetic characteristics, can be more easily and directly developed to match an individual component than to match an illness definition as broad as schizophrenia.Keywords
This publication has 157 references indexed in Scilit:
- Genetics and intermediate phenotypes of the schizophrenia—bipolar disorder boundaryNeuroscience & Biobehavioral Reviews, 2010
- Common variants on chromosome 6p22.1 are associated with schizophreniaNature, 2009
- Common variants conferring risk of schizophreniaNature, 2009
- Impaired maturation of dendritic spines without disorganization of cortical cell layers in mice lacking NRG1/ErbB signaling in the central nervous systemProceedings of the National Academy of Sciences, 2009
- Neuregulin 1 in neural development, synaptic plasticity and schizophreniaNature Reviews Neuroscience, 2008
- Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophreniaTrends in Neurosciences, 2008
- Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trialNature Medicine, 2007
- Genetic association between schizophrenia and the DISC1 gene in the Scottish populationAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2006
- A schizophrenia-associated mutation of DISC1 perturbs cerebral cortex developmentNature Cell Biology, 2005
- Cholinergic systems and schizophrenia: primary pathology or epiphenomena?Journal of Chemical Neuroanatomy, 2001